SBI Securities
ONCY icon

SBI Securities’s Oncolytics Biotech ONCY Stock Holding History

SBI Securities’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11 Buy
17
+3
+21% +$2 ﹤0.01% 3993
2026
Q2 		$13 Buy
+14
New +$13 ﹤0.01% 3903

Other funds holding ONCY

Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
Doliver Advisors
Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return
Badgley Phelps Wealth Managers
Badgley Phelps Wealth Managers Seattle, Washington $5.8B AUM 25.34% 1-Year Est. Return
Professional Advisory Services
Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return
Valley National Advisers
Valley National Advisers Bethlehem, Pennsylvania $909M AUM 22.39% 1-Year Est. Return
Cedar Mountain Advisors
Cedar Mountain Advisors Lake Oswego, Oregon $590M AUM 11.27% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

SBI Securities's ONCY Position: Q3 2026 in Review

SBI Securities increased its Oncolytics Biotech (ONCY) stake by 21% in Q3 2026, buying an estimated $2 and bringing the position to 17 shares worth $11. The position accounts for ﹤0.01% of the portfolio, ranked #3993.

SBI Securities first reported a position in ONCY in Q2 2026 and has held it in 2 quarters since. The position peaked at $13 in Q2 2026. 12 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.

  • SBI Securities held 17 shares of Oncolytics Biotech worth $11 as of Q3 2026.
  • SBI Securities bought 3 Oncolytics Biotech shares in Q3 2026, an estimated $2.
  • Oncolytics Biotech made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3993 holding.
  • SBI Securities first reported a position in Oncolytics Biotech in Q2 2026 and has held it in 2 quarters since.
  • SBI Securities's Oncolytics Biotech position peaked at $13 in Q2 2026.
  • 12 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.